We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-11.26%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.3B
AUM Growth
+$1.07B
Cap. Flow
+$2.36B
Cap. Flow %
22.99%
Top 10 Hldgs %
47.42%
Holding
1,109
New
276
Increased
252
Reduced
500
Closed
79

Top Buys

Rank Stock Value
1
WES icon
Western Midstream Partners
WES
+$619M
2
CCJ icon
Cameco
CCJ
+$146M
3
HESM icon
Hess Midstream
HESM
+$80.6M
4
VZ icon
Verizon
VZ
+$58.6M
5
MSFT icon
Microsoft
MSFT
+$51.2M

Sector Composition

Rank Sector Weight
1 Energy 60.43%
2 Technology 6.16%
3 Healthcare 4.82%
4 Consumer Discretionary 4.16%
5 Industrials 3.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLNC icon
301
Fluence Energy
FLNC
$1.78B
$2.24M 0.02%
236,075
-7,861
-3% -$76.5K
IS
302
DELISTED
ironSource Ltd.
IS
$2.23M 0.02%
+937,293
New +$3.14M
NET icon
303
Cloudflare
NET
$93B
$2.21M 0.02%
+50,584
New +$3.64M
MRTX
304
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.21M 0.02%
+32,935
New +$2.09M
ARWR icon
305
Arrowhead Research
ARWR
$12.1B
$2.21M 0.02%
+62,730
New +$2.36M
LKFT
306
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$2.19M 0.02%
39,164
-27,998
-42% -$1.66M
PAYX icon
307
Paychex
PAYX
$40.4B
$2.15M 0.02%
18,898
+4,489
+31% +$564K
DNLI icon
308
Denali Therapeutics
DNLI
$3.67B
$2.15M 0.02%
+72,940
New +$1.91M
CSX icon
309
CSX Corp
CSX
$98.6B
$2.15M 0.02%
73,805
+63,561
+620% +$2.07M
PATH icon
310
UiPath
PATH
$5.62B
$2.15M 0.02%
+117,913
New +$2.2M
MVST icon
311
Microvast
MVST
$267M
$2.11M 0.02%
949,628
-68,852
-7% -$296K
PLTR icon
312
Palantir
PLTR
$295B
$2.07M 0.02%
+228,159
New +$2.26M
DHR icon
313
Danaher
DHR
$135B
$2.04M 0.02%
9,084
-2,476
-21% -$570K
UHT
314
Universal Health Realty Income Trust
UHT
$608M
$2.04M 0.02%
+38,349
New +$2.03M
EMR icon
315
Emerson Electric
EMR
$82.9B
$2.02M 0.02%
25,433
+20,085
+376% +$1.77M
UGI icon
316
UGI
UGI
$8B
$2.02M 0.02%
+52,235
New +$2.02M
BRK.B icon
317
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.01M 0.02%
+7,377
New +$2.31M
ZLAB icon
318
Zai Lab
ZLAB
$2.17B
$2.01M 0.02%
+58,080
New +$2.05M
GTM
319
ZoomInfo Technologies
GTM
$861M
$2M 0.02%
+60,236
New +$2.66M
CYTK icon
320
Cytokinetics
CYTK
$11B
$2M 0.02%
50,812
-35,396
-41% -$1.43M
VGR
321
DELISTED
Vector Group Ltd.
VGR
$1.99M 0.02%
189,797
+129,250
+213% +$1.55M
SMAR
322
DELISTED
Smartsheet Inc.
SMAR
$1.99M 0.02%
+63,195
New +$2.62M
SAFT icon
323
Safety Insurance
SAFT
$1.52B
$1.97M 0.02%
+20,318
New +$1.83M
CDK
324
DELISTED
CDK Global, Inc.
CDK
$1.96M 0.02%
+35,799
New +$1.94M
TEAM icon
325
Atlassian
TEAM
$22B
$1.94M 0.02%
+10,374
New +$2.21M

Similar funds

ALPS Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, ALPS Advisors held 1,109 positions worth $10.3B, up 12% from $9.22B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

ALPS Advisors deployed $2.36B of net new capital in Q2 2022, opening 276 new positions and adding to 252 existing holdings. Its largest new stake was Western Midstream Partners: 24,175,389 shares worth $588M.

By sector, the portfolio is most concentrated in Energy at 60% of assets, down from 66% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Energy Transfer Partners, an estimated $71M trimmed.

  • ALPS Advisors's largest Q2 2022 buy was Western Midstream Partners: 24,175,389 shares worth $588M.
  • ALPS Advisors added most to Hess Midstream in Q2 2022, an estimated $80.6M increase.
  • ALPS Advisors's biggest Q2 2022 reduction was Energy Transfer Partners, cutting an estimated $71M.
  • ALPS Advisors fully exited People's United Financial Inc in Q2 2022, selling an estimated $23.8M.
  • ALPS Advisors's ten largest holdings make up 47% of its $10.3B portfolio in Q2 2022.
  • ALPS Advisors opened 276 new positions and closed 79 in Q2 2022.
  • ALPS Advisors's portfolio value rose 12% quarter-over-quarter to $10.3B.

Based on ALPS Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.